Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PLx Pharma Winddown's share price for the quarter that ended in Sep. 2022 was $0.65. PLx Pharma Winddown's Shares Outstanding (EOP) for the quarter that ended in Sep. 2022 was 29.14 Mil. Therefore, PLx Pharma Winddown's market cap for the quarter that ended in Sep. 2022 was $18.94 Mil.
PLx Pharma Winddown's quarterly market cap
declined
from Mar. 2022 ($111.26 Mil) to Jun. 2022 ($68.46 Mil) and
declined
from Jun. 2022 ($68.46 Mil) to Sep. 2022 ($18.94 Mil).
PLx Pharma Winddown's annual market cap
increased
from Dec. 2019 ($40.01 Mil) to Dec. 2020 ($76.79 Mil) and
increased
from Dec. 2020 ($76.79 Mil) to Dec. 2021 ($220.59 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PLx Pharma Winddown's Enterprise Value for Today is $-9.81 Mil.
PLx Pharma Winddown Market Cap Historical Data
The historical data trend for PLx Pharma Winddown's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PLx Pharma Winddown's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, PLx Pharma Winddown's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PLx Pharma Winddown's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PLx Pharma Winddown's Market Cap distribution charts can be found below:
* The bar in red indicates where PLx Pharma Winddown's Market Cap falls into.
PLx Pharma Winddown Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PLx Pharma Winddown's Market Cap for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PLx Pharma Winddown (OTCPK:PLXPQ) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PLx Pharma Winddown Market Cap Related Terms
Thank you for viewing the detailed overview of PLx Pharma Winddown's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
PLx Pharma Winddown (PLx Pharma Winddown) Business Description
PLx Pharma Winddown Corp Formerly PLx Pharma Inc is a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard drug delivery platform designed to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the GI tract. It believes this platform has the potential to improve the absorption of many drugs currently on the market or in development and to reduce the risk of stomach erosions and ulcers associated with drugs. VAZALORE is a novel formulation of aspirin clinically shown to provide fast, reliable and predictable platelet inhibition for patients with vascular disease and diabetic patients who may be candidates for aspirin therapy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PLXPQ has been successfully added to your 